Detection of anti-annexin IV and V antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus

Journal of Rheumatology

Volumn 26, Issue 8, 1999, Pages 1715-1720

  Satoh, Ayano ^b   Suzuki, Kimihiro ^a   Takayama, Eiji ^b   Kojima, Kyoko ^b   Hidaka, Toshihiko ^b   Kawakami, Makoto ^b   Matsumoto, Isamu ^b   Ohsuzu, Fumitaka ^b  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b NONE

Author keywords

Annexins; Antiphospholipid syndrome; Systemic lupus erythematosus

Indexed keywords

ANTIBODY; BETA2 GLYCOPROTEIN 1; CALCIUM; CARDIOLIPIN; LIPOCORTIN 4; LIPOCORTIN 5; PHOSPHOLIPID; PROTEIN;

ADOLESCENT; ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY TITER; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS;

ADOLESCENT; ADULT; ANNEXIN A4; ANNEXIN A5; ANTIPHOSPHOLIPID SYNDROME; AUTOANTIBODIES; BETA 2-GLYCOPROTEIN I; BINDING, COMPETITIVE; CARDIOLIPINS; FEMALE; GLYCOPROTEINS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PHOSPHATIDYLSERINES;

EID: 0032794523     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Liemann S, Huber R. Three-dimensional structure of annexins. Cell Mol Life Sci 1997;53:516-21.
2. Morgan RO, Fernandez MP. Expression profile and structural divergence of novel human annexin 31. FEBS Lett 1998;434:300-4.
3. Bailey JM. New mechanisms for effects of anti-inflammatory glucocorticoids. Biofactors 1991;3:97-102.
4. Maki M, Murata M, Shidara Y. Inhibitors of platelet aggregation and blood coagulation isolated from the human placenta. Eur J Obstet Gynecol Reprod Biol 1984;17:149-54.
5. Funakoshi T, Heimark RL, Hendrickson LE, McMullen BA, Fujikawa K. Human placental anticoagulant protein: isolation and characterization. Biochemistry 1987;26:5572-8.
6. Thiagarajan P, Tait JF. Binding of annexin V/placental anticoagulant protein I to platelets. Evidence for phosphatidylserine exposure in the procoagulant response of activated platelets. J Biol Chem 1990;265:17420-3.
7. Raynal P, Pollard HB. Annexins: the problem of assessing the biological role for a gene family of multifunctional calcium- and phospholipid-binding proteins. Biochim Biophys Acta 1994;1197:63-93.
8. Hirata F, del Carmine R, Nelson CA, et al. Presence of autoantibody for phospholipase inhibitory protein, lipomodulin, in patients with rheumatic diseases. Proc Natl Acad Sci USA 1981;78:3190-4.
9. Matsuda J, Saitoh N, Gohchi K, Gotoh M, Tsukamoto M. Anti-annexin V antibody in systemic lupus erythematosus patients with lupus anticoagulant and/or anticardiolipin antibody. Am J Hematol 1994;47:56-8.
10. Nakamura N, Kuragaki C, Shidara Y, Yamaji K, Wada Y. Antibody to annexin V has anti-phospholipid and lupus anticoagulant properties. Am J Hematol 1995;49:347-8.
11. Kaburaki J, Kuwana M, Yamamoto M, Kawai S, Ikeda Y. Clinical significance of anti-annexin V antibodies in patients with systemic lupus erythematosus. Am J Hematol 1997;54:209-13.
12. Kraus M, Romisch J, Bastian B, Paques EP, Hartmann AA. Detection of human anti-annexin autoantibodies by enzyme immunoassays. J Immunoassay 1992;13:411-39.
13. Bastian BC, Bernadette N, Römisch J, Kraus M, Broecker E-B. Autoantibodies to annexins: a diagnostic marker for cutaneous disorders? J Dermatol Sci 1994;8:194-202.
14. Dubois T, Bisangni-F A, Coste J, et al. High levels of antibodies to annexin V and VI in patients with rheumatoid arthritis. J Rheumatol 1995;22:1230-4.
15. Satoh A, Takayama E, Kojima K, et al. Expression of carbohydrate-binding protein p33/41 in human tumor cell lines. J Biochem 1996;119:346-52.
16. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
17. Harris EN. Antiphospholipid antibodies. Br J Haematol 1990;74:1-9.
18. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH, Committee for prognosis studies in SLE. Derivation of the SLEDAI. A Disease Activity Index for lupus patients. Arthritis Rheum 1992;35:630-40.
19. Exner T, Triplett DA, Tabemer D, Machin SJ. Guideline for testing and revised criteria for lupus anticoagulants. Thromb Haemost 1991;65:320-2.
20. 2+ dependent carbohydrate-binding protein with monoclonal anti-annexin IV antibodies, AS11 and AS17. Biol Pharm Bull 1997;20:224-9.
21. Harris EN, Gharavi AE, Patel SP, Hughes GRV. Evaluation of the anti-cardiolipin antibody test: report of an International Workshop 4 April 1986. Clin Exp Immunol 1987;68:215-22.
22. 2-glycoprotein I antibody: specificity and clinical significance. Lupus 1996;5:378-80.
23. 2-GPI and role of other phospholipid cofactors. Haemostasis 1994;24:191-203.
24. 2+: monolayer and proteolytic study. Mol Membr Biol 1996;13:241-50.
25. de la Fuente M, Ossa CG. Binding to phosphatidylserine membranes causes a conformational change in the concave face of annexin I. Biophys J 1997;72:383-7.
26. 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J Exp Med 1994;179:457-62.
27. Römisch J, Grote M, Weithmann KU, Heimburger N, Amann E. Annexin proteins PP4 and PP4-X. Comparative characterization of biological activities of placental and recombinant proteins. Biochem J 1990;272:223-9.
28. Funakoshi T, Abe M, Sakata M, et al. Novel anticoagulant peptides from the functional site of human placental anticoagulant protein. Biochem Int 1991;24:173-80.
29. Reutelingsperger CP, van Heerde WL. Annexin V, the regulator of phosphatidylserine-catalyzed inflammation and coagulation during apoptosis. Cell Mol Life Sci 1997;53:527-32.
30. Arnout J, Wittevrongel C, Vanrusselt M, Hoylaerts M, Vermylen J. Beta-2-glycoprotein I dependent lupus anticoagulants from stable bivalent antibody beta-2-glycoprotein I complexes on phospholipid surfaces. Thromb Haemost 1998;79:79-86.
31. Keeling DM, Wilson AJ, Mackie IJ, Isenberg DA, Machin SJ. Role of beta 2-glycoprotein I and anti-phospholipid antibodies in activation of protein C in vitro. J Clin Pathol 1993;46:908-11.
32. Kaneko N, Matsuda R, Hosoda S, Kajita T, Ohta Y. Measurement of plasma annexin V by ELISA in the early detection of acute myocardial infarction. Clin Chim Acta 1996;251:65-80.
33. Casciola-Rosen L, Rosen A, Petri M, Schlissel M. Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: implications for coagulation events and antigenic spread in systemic lupus erythematosus. Proc Natl Acad Sci USA 1996;93:1624-9.
34. Nakamura N, Ban T, Yamaji K, Yoneda Y, Wada Y. Localization of the apoptosis-inducing activity of lupus anticoagulant in an annexin V-binding antibody subset. J Clin Invest 1998;101:1951-9.
35. Kojima K, Utsumi H, Ogawa H, Matsumoto I. Highly polarized expression of carbohydrate-binding protein p33/41 (annexin IV) on the apical plasma membrane of epithelial cells in renal proximal tubules. FEBS Lett 1994;342:313-8.
36. Kassam G, Manro A, Braat CE, Louie P, Fitzpatrick SL, Waisman DM. Characterization of the heparin binding properties of annexin II tetramer. J Biol Chem 1997;272:15093-100.
37. Kojima K, Ogawa HK, Seno N, et al. Carbohydrate-binding proteins in bovine kidney have consensus amino acid sequences of annexin family proteins. J Biol Chem 1992;267:20536-9.
38. Kojima K, Yamamoto K, Irimura T, Osawa T, Ogawa H, Matsumoto I. Characterization of carbohydrate-binding protein p33/41: relation with annexin IV, molecular basis of the doublet forms (p33 and p41), and modulation of the carbohydrate binding activity by phospholipids. J Biol Chem 1996;271:7679-85.
39. Ishitsuka R, Kojima K, Ogawa H, Matsumoto I. Glycosaminoglycan-binding activity of annexin IV, annexin V and annexin VI. J Biol Chem 1998;273:9935-41.